IRIS
TRAVELLI, CRISTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.103
AS - Asia 816
EU - Europa 582
SA - Sud America 136
AF - Africa 65
OC - Oceania 3
Totale 2.705
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.072
SG - Singapore 247
CN - Cina 213
HK - Hong Kong 138
IE - Irlanda 127
RU - Federazione Russa 110
BR - Brasile 109
IT - Italia 98
VN - Vietnam 84
DE - Germania 75
FR - Francia 46
FI - Finlandia 43
ZA - Sudafrica 35
GB - Regno Unito 31
IN - India 30
BD - Bangladesh 17
IQ - Iraq 16
CA - Canada 12
JP - Giappone 12
MX - Messico 11
AR - Argentina 10
BE - Belgio 9
ES - Italia 9
MA - Marocco 8
CM - Camerun 7
CO - Colombia 7
ID - Indonesia 6
PH - Filippine 6
PK - Pakistan 6
SA - Arabia Saudita 6
TR - Turchia 6
AT - Austria 5
EG - Egitto 5
LT - Lituania 4
PL - Polonia 4
SE - Svezia 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
EC - Ecuador 3
JO - Giordania 3
KE - Kenya 3
KR - Corea 3
MY - Malesia 3
NL - Olanda 3
NP - Nepal 3
AL - Albania 2
AU - Australia 2
AZ - Azerbaigian 2
CH - Svizzera 2
DZ - Algeria 2
GE - Georgia 2
PE - Perù 2
TH - Thailandia 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
UA - Ucraina 2
BO - Bolivia 1
CI - Costa d'Avorio 1
CL - Cile 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GA - Gabon 1
GF - Guiana Francese 1
GP - Guadalupe 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
JM - Giamaica 1
KG - Kirghizistan 1
KH - Cambogia 1
MD - Moldavia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
PY - Paraguay 1
RO - Romania 1
SI - Slovenia 1
TW - Taiwan 1
VE - Venezuela 1
Totale 2.705
Salva come PNG Salva come JPEG
Città #
San Jose 181
Hong Kong 137
Singapore 129
Dublin 127
Ashburn 122
Chandler 113
Dallas 95
Beijing 77
Boardman 41
Council Bluffs 41
Lauterbourg 40
Munich 40
Johannesburg 30
Los Angeles 30
Redondo Beach 30
Ho Chi Minh City 29
Helsinki 25
New York 22
Buffalo 20
Orem 20
Shanghai 20
Moscow 19
The Dalles 18
Turku 18
Hanoi 16
Ann Arbor 15
Falkenstein 15
Lawrence 15
Princeton 15
Milan 14
São Paulo 14
Nuremberg 13
Medford 11
Santa Clara 11
Chicago 10
Tokyo 10
Baghdad 9
Bolzaneto 9
Brussels 9
Wilmington 9
Turin 8
Guangzhou 7
Rome 7
Brooklyn 6
Da Nang 6
Manchester 6
Mexico City 5
Mumbai 5
San Francisco 5
Bossico 4
Columbus 4
Fortaleza 4
Norwalk 4
Novara 4
Rio de Janeiro 4
Seattle 4
Washington 4
Yaoundé 4
Biên Hòa 3
Boston 3
Casablanca 3
Charlotte 3
Chennai 3
Douala 3
Haiphong 3
Hangzhou 3
Houston 3
Inverigo 3
Jeddah 3
Joinville 3
Londrina 3
Medellín 3
Montreal 3
Nairobi 3
Richmond 3
Salvador 3
Seoul 3
Shijiazhuang 3
Stockholm 3
Tianjin 3
Toronto 3
Warsaw 3
Amman 2
Ankara 2
Atlanta 2
Augusta 2
Barbianello 2
Barra Mansa 2
Belo Horizonte 2
Bengaluru 2
Brasília 2
Bắc Ninh 2
Cairo 2
Des Moines 2
Duque de Caxias 2
Durban 2
Faisalabad 2
Genoa 2
Greensboro 2
Gurugram 2
Totale 1.818
Salva come PNG Salva come JPEG
Nome #
OXER1 and RACK1-associated pathway: a promising drug target for breast cancer progression 117
Neutralization of extracellular NAMPT (nicotinamide phosphoribosyltransferase) ameliorates experimental murine colitis 106
Ribosomes as a nexus between translation and cancer progression: Focus on ribosomal Receptor for Activated C Kinase 1 (RACK1) in breast cancer 99
Design, synthesis, and biological evaluation of combretabenzodiazepines: A novel class of anti-tubulin agents 95
Discovery of Highly Potent Benzimidazole Derivatives as Indoleamine 2,3-Dioxygenase-1 (IDO1) Inhibitors: From Structure-Based Virtual Screening to in Vivo Pharmacodynamic Activity 93
A nicotinamide phosphoribosyltransferase–GAPDH interaction sustains the stress-induced NMN/NAD+ salvage pathway in the nucleus 91
Identification of Novel Triazole-Based Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors Endowed with Antiproliferative and Antiinflammatory Activity 90
Increased plasma nicotinamide phosphoribosyltransferase is associated with a hyperproliferative phenotype and restrains disease progression in MPN-associated myelofibrosis 89
Disruption of epithelial barrier integrity via altered GILZ/c-Rel/RACK1 signaling in inflammatory bowel disease (IBD) 88
Extracellular nicotinamide phosphoribosyltransferase (eNAMPT) neutralization counteracts T cell immune evasion in breast cancer 86
Nicotinamide phosphoribosyltransferase acts as a metabolic gate for mobilization of myeloid-derived suppressor cells 86
Data on metabolic stability, aqueous solubility and CYP inhibition of novel triazole-based nicotinamide phosphoribosyltransferase (NAMPT) inhibitors 85
Identification of potent triazolylpyridine nicotinamide phosphoribosyltransferase (NAMPT) inhibitors bearing a 1,2,3-triazole tail group 82
Molecular regulations of circadian rhythm and implications for physiology and diseases 81
Molecular characterization of membrane steroid receptors in hormone-sensitive cancers 81
Mucosal Overexpression of Thymic Stromal Lymphopoietin and Proinflammatory Cytokines in Patients With Autoimmune Atrophic Gastritis 80
The Cytokine Nicotinamide Phosphoribosyltransferase (eNAMPT; PBEF; Visfatin) Acts as a Natural Antagonist of C-C Chemokine Receptor Type 5 (CCR5) 79
Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin) is a tumoural cytokine released from melanoma 75
Recent Advances in NAMPT Inhibitors: A Novel Immunotherapic Strategy 72
Prostaglandin E2 and cancer: Insight into tumor progression and immunity 72
Involvement of eNAMPT/TLR4 inflammatory signaling in progression of non-alcoholic fatty liver disease, steatohepatitis, and fibrosis 70
eNAMPT/TLR4 inflammatory cascade activation is a key contributor to SLE Lung vasculitis and alveolar hemorrhage 65
Extracellular nicotinamide phosphoribosyltransferase boosts IFNγ-induced macrophage polarization independently of TLR4 59
Identification of novel aza-analogs of TN-16 as disrupters of microtubule dynamics through a multicomponent reaction 57
A novel potent nicotinamide phosphoribosyltransferase inhibitor synthesized via click chemistry 56
Autophagy and inflammation an intricate affair in the management of obesity and metabolic disorders: evidence for novel pharmacological strategies? 54
NAMPT: A pleiotropic modulator of monocytes and macrophages 54
Pro- and anti-inflammatory cytokines: the hidden keys to autoimmune gastritis therapy 53
Insight Into Nicotinamide Adenine Dinucleotide Homeostasis as a Targetable Metabolic Pathway in Colorectal Cancer 53
Medicinal chemistry of nicotinamide phosphoribosyltransferase (NAMPT) inhibitors 53
Extracellular nicotinamide phosphoribosyltransferase, a new cancer metabokine 52
NAMPT and NAPRT serum levels predict response to anti-TNF therapy in inflammatory bowel disease 50
NAD depletion by FK866 induces autophagy 45
Identification of a novel NAMPT inhibitor by combinatorial click chemistry and chemical refinement 43
Triazole-curcuminoids: A new class of derivatives for 'tuning' curcumin bioactivities? 42
Metabolic regulation of suppressive myeloid cells in cancer 41
Targeting Transient Receptor Potential Vanilloid 1 (TRPV1) Channel Softly: The Discovery of Passerini Adducts as a Topical Treatment for Inflammatory Skin Disorders 41
Characterization of NAD uptake in mammalian cells 41
The NAMPT inhibitor FK866 reverts the damage in spinal cord injury 39
Reciprocal potentiation of the antitumoral activities of FK866, an inhibitor of nicotinamide phosphoribosyltransferase, and etoposide or cisplatin in neuroblastoma cells 33
Synthesis and Degradation of Adenosine 5′-Tetraphosphate by Nicotinamide and Nicotinate Phosphoribosyltransferases 32
Nicotinamide phosphoribosyltransferase (NAMPT) is over-expressed in melanoma lesions 28
Totale 2.808
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.297
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.297
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202297 1 1 1 0 2 1 0 7 5 1 10 68
2022/2023317 17 34 15 22 22 34 0 18 143 2 8 2
2023/2024108 9 13 6 11 17 29 0 20 1 1 0 1
2024/2025710 38 45 10 49 2 48 62 30 155 18 111 142
2025/20261.543 126 111 164 125 203 51 280 82 134 131 104 32
2026/202714 14 0 0 0 0 0 0 0 0 0 0 0
Totale 2.808